Eruptive cherry angiomas developing in a patient treated with ramucirumab
- 30 November 2017
- journal article
- letter
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 57 (5) , 709-711
Abstract
(2018). Eruptive cherry angiomas developing in a patient treated with ramucirumab. Acta Oncologica: Vol. 57, No. 5, pp. 709-711.Keywords
This publication has 10 references indexed in Scilit:
- Predisposing factors for eruptive cherry angiomas: New insights from an observational studyInternational Journal of Dermatology, 2016
- Evolution of ramucirumab in the treatment of cancer – A review of literatureJournal of Oncology Pharmacy Practice, 2016
- Somatic p.T771R KDR (VEGFR2) Mutation Arising in a Sporadic Angioma During Ramucirumab TherapyJAMA Dermatology, 2015
- Cutaneous manifestations of anti-angiogenic therapy in oncology: Review with focus on VEGF inhibitorsCritical Reviews in Oncology/Hematology, 2014
- Multiple cutaneous malignancies and cherry hemangiomas in a vitiligo patient treated with topical nitrogen mustardDermatologic Therapy, 2013
- Eruptive Cherry Hemangiomatosis Associated With Multicentric Castleman DiseaseJAMA Dermatology, 2013
- Eruptive cherry angiomas associated with vitiligo: Provoked by topical nitrogen mustard?The Journal of Dermatology, 2006
- Eruptive angiomas associated with graft-versus-host diseaseBritish Journal of Dermatology, 2005
- Cherry Angiomas Associated with Exposure to BromidesDermatology, 2001
- Eruptive Angiomas After Treatment With Cyclosporine in a Patient With PsoriasisArchives of Dermatology, 1998